(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

Nike Sees Weakness Persisting; US Decides Against Renewing USMCA
22:34

Chip Stocks’ Best Quarter Ever Is Ending With Some Wild Swings
22:33

Supreme Court Thwarts Trump Bid to Oust Fed’s Cook
20:43